高HPV流行区口咽癌发病率持续上升:2011至2014年丹麦人群研究
该研究基于丹麦头颈癌组与病理数据库(n=700),对2011至2014年东部丹麦口咽鳞癌重新评估p16免疫组化及HPV DNA PCR和基因分型,发现62%(432/700)肿瘤为HPV阳性,总发病率从2011年4.0升至2014年4.5(每10万人),主要由HPV阳性扁桃体癌和舌根癌驱动;HPV16占86%。
要点
- 2011至2014年东部丹麦口咽鳞癌总发病率从4.0升至4.5(每10万人)。
- 62%(432/700)口咽鳞癌为HPV阳性,其中HPV16 DNA占86%,其他基因型占14%。
- 作者预测2016年东部丹麦HPV阳性口咽鳞癌数量将超过宫颈癌。
核心结论
- 口咽鳞癌发病率上升主要由HPV阳性口咽鳞癌驱动,62%肿瘤为HPV阳性,HPV16为主要基因型但14%为其他基因型。
- 作者预测2016年东部丹麦HPV阳性口咽鳞癌数量将超过宫颈癌。
研究设计与样本
- 基于丹麦头颈癌组和丹麦病理数据库的人群研究,纳入2011至2014年东部丹麦口咽鳞癌患者n=700,肿瘤重新评估采用p16免疫组化、HPV DNA聚合酶链反应(PCR)及二代测序基因分型。
主要发现
- 62%(432/700)肿瘤为HPV阳性。
- 口咽鳞癌总发病率(每10万人)从2011年4.0升至2014年4.5,主要因HPV阳性扁桃体鳞癌和HPV阳性舌根鳞癌增加,HPV阴性口咽鳞癌数量在研究期间也增加。
- HPV阳性肿瘤中86%为HPV16 DNA阳性,6%为HPV33 DNA,4%为HPV35 DNA,3%为其他型别(包括HPV18、26、31、45、56、58、59和HPV67)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) is a critical element in the rising incidence of oropharyngeal squamous cell carcinoma (OPSCC), although whether this trend will continue, and the types of HPV responsible, are currently unknown. We previously demonstrated an increased incidence of HPV-related OPSCC in the high HPV prevalence area of Eastern Denmark from 2000 to 2010. Therefore, we investigated if the incidence for OPSCC continued to rise, the association to HPV and putative HPV-types in Eastern Denmark from 2011 to 14. We then projected the expected incidence of OPSCC versus cervical cancer through to 2020. PATIENTS AND METHODS: Patients with OPSCC (tonsillar squamous cell carcinoma [TSCC] and base of tongue squamous cell carcinoma [BSCC]) were identified via the Danish Head and Neck Cancer Group and the Danish Pathology Databank (n = 700). Tumours were re-reviewed and assessed using p16 immunohistochemistry, HPV DNA polymerase chain reaction (PCR), with genotyping by next generation sequencing. RESULTS: Sixty-two percent (432/700) of tumours were HPV-positive (HPV+). The total incidence rate (per 100.000) for OPSCC increased from 4.0 in 2011 to 4.5 in 2014, primarily due to a rise in HPV+ TSCCs and HPV+ BSCCs, although numbers of HPV-negative (HPV-) OPSCC also increased during the study period. The majority of HPV+ tumours were HPV16 DNA positive (86%), but we also identified HPV33 DNA (6%), HPV35 DNA (4%) and others (3%), including HPV18, 26, 31, 45, 56, 58, 59 and HPV67. CONCLUSION: An increasing incidence of OPSCC is driven primarily by HPV+ OPSCC. Sixty-two percent of tumours were HPV+, which is a high-prevalence, although the lower number of HPV- cases has yet to stabilise. HPV16 was the predominant genotype, although a significant proportion (14%) was of another genotype. Our projections suggest that the number of HPV+ OPSCC will exceed that of cervical cancer in 2016 in Eastern Denmark.
引用
- Carlander AF, Grønhøj Larsen C, Jensen DH, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014. Eur J Cancer. 2016. PMID: 27888679. doi:10.1016/j.ejca.2016.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。